Last SFr.266.70 CHF
Change Today -1.50 / -0.56%
Volume 185.3K
ROG On Other Exchanges
Symbol
Exchange
OTC US
OTC US
OTC US
Xetra
SIX Swiss Ex
Xetra
SIX Swiss Ex
Mexico
Frankfurt
As of 3:55 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard H. Scheller Ph.D.

Head of Genentech Research & Early Development, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 6 different industries.

See Board Relationships
61--

Background*

Dr. Richard H. Scheller, Ph.D. serves as an Executive Vice President of Research & Early Development for Genentech, Inc. Dr. Scheller is responsible for setting the strategy for Genentech's research and drug discovery activities. He has been the Head of Genentech Research & Early Development at Roche Holding AG since 2009. He served as the Chief Scientific Officer of Genentech Inc. since June 2008 and also served its Executive Vice President of Research since September ...

Read Full Background

Corporate Headquarters*

Grenzacherstrasse 124
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

2012-Present
Director

Education*

Bachelor's Degree
University of Wisconsin - Madison
Doctorate
California Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.266.70 CHF -1.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$8.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.